Progyny (NASDAQ:PGNY) Updates Q4 2024 Earnings Guidance

Progyny (NASDAQ:PGNY) updated its fourth quarter 2024 earnings guidance on Tuesday. The company provided EPS guidance of 0.310-0.350 for the period, compared to the consensus EPS estimate of 0.140. The company issued revenue guidance of $266.2 million-$281.2 million, compared to the consensus revenue estimate of $292.7 million. Progyny also updated its FY 2024 guidance to 1.540-1.570 EPS.

Progyny Price Performance

Shares of NASDAQ PGNY opened at $17.18 on Wednesday. Progyny has a 1 year low of $13.93 and a 1 year high of $42.08. The company’s 50-day moving average is $17.88 and its 200 day moving average is $23.62. The stock has a market capitalization of $1.55 billion, a P/E ratio of 27.27, a P/E/G ratio of 1.61 and a beta of 1.44.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Leerink Partners dropped their price target on Progyny from $25.00 to $21.00 and set a “market perform” rating on the stock in a research report on Thursday, September 19th. Truist Financial lowered their price target on shares of Progyny from $33.00 to $26.00 and set a “buy” rating for the company in a research report on Thursday, September 19th. Canaccord Genuity Group cut their price objective on shares of Progyny from $24.00 to $18.00 and set a “hold” rating on the stock in a report on Friday, September 20th. Jefferies Financial Group dropped their price target on Progyny from $31.00 to $24.00 and set a “buy” rating on the stock in a research report on Thursday, September 19th. Finally, JPMorgan Chase & Co. reduced their price target on Progyny from $31.00 to $22.00 and set an “overweight” rating for the company in a report on Thursday, September 19th. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $27.73.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.